Sign in
4

Changes in Ownership

IONIS PHARMACEUTICALS INC Filed Acc 0000874015-23-000226

EVP, Chief Scientific Officer sold 22,612 shares at an average $49.58 ($1,121,195)

  • EVP, Chief Scientific Officer acquired 22,612 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

BENNETT C FRANK · EVP, Chief Scientific Officer

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2023-12-14 Exercise or conversion : show line 1 in the form 10b5-1 +14,002 $47.34 $662,855 79,756 D
2023-12-14 Sale : show line 2 in the form 10b5-1 −14,002 $49.21 $689,085 65,754 D
2023-12-14 Exercise or conversion : show line 3 in the form 10b5-1 +8,610 $47.34 $407,597 74,364 D
2023-12-14 Sale : show line 4 in the form 10b5-1 −8,610 $50.19 $432,110 65,754 D
Open-market sales · 22,612 sh · avg $49.58 · $1,121,195

Table II: Derivative

2 lines
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2023-12-14 Exercise or conversion : show line 5 in the form 10b5-1 Non-Qualified Stock Option (right to buy) −14,002 $47.34 2024-01-02 14,002 31,223 D
2023-12-14 Exercise or conversion : show line 6 in the form 10b5-1 Non-Qualified Stock Option (right to buy) −8,610 $47.34 2024-01-02 8,610 22,613 D
Loading xslF345X05/edgardoc.xml…